Time Frame Analysis of Medical Device Approval, New Health Technology Assessment, and Reimbursement Decision-Making in Korea. [PDF]
Kim JH.
europepmc +1 more source
Estimating return on investment of four interventions based on health technology assessment studies in India. [PDF]
Saha S, Joshi K, Raval D, Saxena D.
europepmc +1 more source
What is the Value of Developing an HTA Process? [PDF]
Murphy P +4 more
europepmc +1 more source
Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligence. [PDF]
Versteeg JW +8 more
europepmc +1 more source
Health technology assessment system in Tanzania: Is it a championing system or still a system lagging behind? [PDF]
Mrisho M +9 more
europepmc +1 more source
Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from Italy. [PDF]
Meregaglia M +4 more
europepmc +1 more source
Health technology assessment in Eastern Europe and Central Asia: an updated SWOT analysis. [PDF]
Sucu R +4 more
europepmc +1 more source
Impact of Market Access Delays on Time to Patient Access: Multi-Country Comparative Analysis Assessing the First Commercial Launch Indications for Five Oncology Medicines Across Europe and Canada. [PDF]
Crean B +4 more
europepmc +1 more source
Whose Values Define Value? Procedural Justice and the Personal Utility of Clinical Genomic Testing. [PDF]
Halley MC.
europepmc +1 more source
Requirements for patient-reported outcomes and data analytics in health technology assessment in England, France and Germany, and the need for methods harmonization across European markets: a qualitative interview study. [PDF]
DiModica L +7 more
europepmc +1 more source

